Product Information

RISPERIDONE ER 25 MG VIAL is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $368.9341 per EA under NDC 70748027013. Its NADAC has been published 46 times since Jan 7, 2026.

FDA first approved this application on Sep 2, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

RISPERIDONE ER 25 MG VIAL

risperidone
$368.9341per EA
High Outlier

NDC

70748027013

Classification

Generic

Dosage Form

KIT

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211220

FDA Approved

9/2/2025

TE Code

AB

On Market Since

10/17/2025

Price Statistics

The NADAC for RISPERIDONE ER 25 MG VIAL has been published 46 times since Jan 7, 2026, and over the history we have for it it has declined 24.8%. The table below summarizes its recorded NADAC range and movement.

Current price$368.9341 per EA
All-time high$490.5793 (Jan 14, 2026)
All-time low$349.1772 (Oct 21, 2026)
52-week high$490.5793
52-week low$349.1772
Median price$392.4869
Average price$413.9879
Largest weekly change-11.0% (Jun 17, 2026)
Weeks tracked46
Tracking sinceJan 7, 2026

Price History

1W

+5.7%

1M

+3.9%

3M

+4.4%

6M

-11.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-24.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RISPERIDONE ER 25 MG VIAL?

The current National Average Drug Acquisition Cost (NADAC) for RISPERIDONE ER 25 MG VIAL, manufactured by Lupin Pharmaceuticals Inc., is $368.9341 per EA (NDC 70748027013), effective Nov 18, 2026.

How has the price of RISPERIDONE ER 25 MG VIAL changed over time?

Over the history we have for it, the NADAC for RISPERIDONE ER 25 MG VIAL has declined 24.8%. It has been tracked across 46 weekly CMS publications since Jan 7, 2026.

What are the highest and lowest recorded NADAC prices for RISPERIDONE ER 25 MG VIAL?

Since Jan 7, 2026, the NADAC for RISPERIDONE ER 25 MG VIAL has ranged from a low of $349.1772 (Oct 21, 2026) to a high of $490.5793 (Jan 14, 2026), with a median of $392.4869 per EA.

Are there cheaper alternatives to RISPERIDONE ER 25 MG VIAL?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RISPERDAL CONSTA 12.5 MG VIAL, is $318.1150 per EA — about 14% below RISPERIDONE ER 25 MG VIAL.

Who manufactures RISPERIDONE ER 25 MG VIAL?

RISPERIDONE ER 25 MG VIAL (NDC 70748027013) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.